These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 14966870

  • 21. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA, Rimsza LM, Murphy SP.
    Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
    [Abstract] [Full Text] [Related]

  • 22. TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA.
    Han Y, Zhou ZH, Ransohoff RM.
    J Immunol; 1999 Aug 01; 163(3):1435-40. PubMed ID: 10415044
    [Abstract] [Full Text] [Related]

  • 23. Pathologic expression of MHC class II is driven by mitogen-activated protein kinases.
    Martins I, Deshayes F, Baton F, Forget A, Ciechomska I, Sylla K, Aoudjit F, Charron D, Al-Daccak R, Alcaide-Loridan C.
    Eur J Immunol; 2007 Mar 01; 37(3):788-97. PubMed ID: 17304627
    [Abstract] [Full Text] [Related]

  • 24. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE, Cooper S, Hangoc G, Chang CH.
    Exp Hematol; 2006 Aug 01; 34(8):1078-84. PubMed ID: 16863914
    [Abstract] [Full Text] [Related]

  • 25. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
    Sartoris S, Valle MT, Barbaro AL, Tosi G, Cestari T, D'Agostino A, Megiovanni AM, Manca F, Accolla RS.
    J Immunol; 1998 Jul 15; 161(2):814-20. PubMed ID: 9670958
    [Abstract] [Full Text] [Related]

  • 26. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L, Castellani P, Meazza R, Tosi G, De Lerma Barbaro A, Procopio FA, Comes A, Zardi L, Ferrini S, Accolla RS.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [Abstract] [Full Text] [Related]

  • 27. Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2.
    Xi H, Eason DD, Ghosh D, Dovhey S, Wright KL, Blanck G.
    Oncogene; 1999 Oct 21; 18(43):5889-903. PubMed ID: 10557076
    [Abstract] [Full Text] [Related]

  • 28. Inhibitor (IK) of IFN-gamma induced HLA class II antigens expression also inhibits HLA class II constitutive expression in the human Raji B cell line.
    Vedrenne J, Assier E, Pereno R, Bouzinba-Segard H, Azzarone B, Jasmin C, Charron D, Krief P.
    Oncogene; 1997 Mar 27; 14(12):1453-61. PubMed ID: 9136989
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant.
    Zhou H, Su HS, Zhang X, Douhan J, Glimcher LH.
    J Immunol; 1997 May 15; 158(10):4741-9. PubMed ID: 9144488
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Capsaicin inhibits IFN-gamma-induced MHC class II expression by suppressing transcription of class II transactivator gene in murine peritoneal macrophages.
    Mahmoud ME, Nikami H, Shiina T, Takewaki T, Shimizu Y.
    Int Immunopharmacol; 2010 Jan 15; 10(1):86-90. PubMed ID: 19825429
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
    Walter W, Lingnau K, Schmitt E, Loos M, Maeurer MJ.
    Br J Cancer; 2000 Nov 15; 83(9):1192-201. PubMed ID: 11027433
    [Abstract] [Full Text] [Related]

  • 37. Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression.
    Peijnenburg A, Gobin SJ, van Eggermond MC, Godthelp BC, van Graafeiland N, van den Elsen PJ.
    J Immunol; 1997 Sep 15; 159(6):2720-7. PubMed ID: 9300692
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.